Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A COMMON cough medicine could help protect people with Parkinson’s against dementia. Around 145,000 people in the UK have ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression.Researchers at Lawson Research ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

For advancements to be made in pathophysiology and medication development of Parkinson’s disease, reliable disease models need ... By consistently adapting to new regulatory challenges and guidelines, ...